Loading video...

Video Failed to Load

Go Home

🚨 A HARVARD TRAINED MD JUST EXPLAINED WHY IVERMECTIN IS BEING STUDIED IN CANCER RESEARCH AGAIN And the internet is paying VERY close attention. Dr. Shintani says researchers have explored how Ivermectin may interact with cancer cells in laboratory and preclinical studies involving: • Breast cancer • Prostate cancer...

JoeTippen's profile picture

Joe Tippens

125,167 subscribers

10,621 views • 1 month ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure
3:28

🚨 “THEY CALLED IT HORSE PASTE… WHILE SCIENTISTS WERE STUDYING IT FOR CANCER AND CHEMO RESISTANCE.” That’s why the Ivermectin conversation refuses to die. According to researchers studying repurposed medicine, Ivermectin is one of the most fascinating molecules ever discovered because it appears to interact with completely different biological pathways depending on the disease being studied. In parasites, researchers found it affects chloride channels. In viruses, studies explored how it may interfere with replication pathways. And in cancer research, scientists have investigated how Ivermectin may interact with tumor proliferation pathways, cancer stem like cells, and chemotherapy resistance mechanisms. Researchers believe cancer stem cells may play a major role in: • Recurrence • Metastasis • Treatment resistance Traditional chemotherapy mainly targets rapidly dividing cells, but scientists are now studying whether Ivermectin may affect more resistant stem like cancer cells differently in laboratory settings. There are also preclinical studies investigating how Ivermectin may help restore chemotherapy sensitivity in resistant tumor cells at the molecular level. And then there’s another reason people keep talking about it: Some researchers have explored whether the same pathways involved in abnormal tumor growth may also be involved in conditions like fibroids, lipomas, and endometriosis. That’s why the repurposed medicine conversation has exploded far beyond COVID. If you’re researching Ivermectin, Fenbendazole, or Mebendazole, many choose PharmacyinUSA for worldwide and discreet delivery. #Ivermectin #HorseDewormer #CancerCure

PharmacyinUSA

15,268 views • 1 month ago

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?
3:41

In an interview, Dr. Kathleen Ruddy, a distinguished breast cancer surgeon, author, and inventor, shared groundbreaking insights on repurposed drugs for cancer treatment. She discussed how medications like ivermectin, mebendazole, sildenafil, metformin, aspirin, doxycycline, and vitamin C show promise in targeting cancer stem cells, the drivers of tumor regrowth. “Cancer stem cells are the real bad boys,” Dr. Ruddy stated, explaining that chemotherapy and radiation often fail to eliminate them, leading to cancer recurrence. Preclinical studies show combinations like doxycycline and vitamin C can eradicate over 90% of cancer stem cells, with doxycycline, azithromycin, and vitamin C proving equally effective. These affordable, FDA-approved drugs could halt tumors without harming patients. Dr. Ruddy praised Dr. Paul Marik’s Cancer Care monograph as a must-read for its analysis of repurposed drugs. Her mission is to cure cancer, not manage it as a chronic disease. “Patients want to live without cancer,” she emphasized. Through her work, she’s studying these therapies’ impact on cancers like breast, prostate, and lung. “Kill the cancer, or the cancer will kill you,” Dr. Ruddy urged. Could repurposed drugs transform cancer care?

Camus

113,278 views • 1 year ago

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

159,980 views • 1 year ago

Shocking research reveals ivermectin & mebendazole may target cancer stem cells, disrupt microtubules, and starve tumors of glucose. Is there a hidden link between parasitic infections and cancer?
2:57

Shocking research reveals ivermectin & mebendazole may target cancer stem cells, disrupt microtubules, and starve tumors of glucose. Is there a hidden link between parasitic infections and cancer?

Redacted

19,138 views • 2 months ago

Ivermectin is often recognized – 2nd to penicillin – for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists, like Rachel Maddow, told you it was a “dangerous horse dewormer.” Well, now we are learning that ivermectin has profound anti-cancer properties. Renowned cardiologist Dr. Peter McCullough told Brannon Howse, “There are now multiple papers demonstrating preclinical models that ivermectin has anti-cancer properties.” He added that curcumin, an active compound found in turmeric, also has anti-cancer properties. Ivermectin’s potential as an anti-cancer drug is now being taken seriously, as the Burzynski Center in Texas and the Brio-Medical Center in Arizona are using ivermectin “more in protocol format,” Dr. McCullough revealed. Dr. McCullough is not alone in his optimistic outlook on using ivermectin as a potential cancer treatment. In an interview with The Epoch Times, Cancer surgeon Dr. Kathleen Ruddy revealed that she has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.
1:18

Ivermectin is often recognized – 2nd to penicillin – for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists, like Rachel Maddow, told you it was a “dangerous horse dewormer.” Well, now we are learning that ivermectin has profound anti-cancer properties. Renowned cardiologist Dr. Peter McCullough told Brannon Howse, “There are now multiple papers demonstrating preclinical models that ivermectin has anti-cancer properties.” He added that curcumin, an active compound found in turmeric, also has anti-cancer properties. Ivermectin’s potential as an anti-cancer drug is now being taken seriously, as the Burzynski Center in Texas and the Brio-Medical Center in Arizona are using ivermectin “more in protocol format,” Dr. McCullough revealed. Dr. McCullough is not alone in his optimistic outlook on using ivermectin as a potential cancer treatment. In an interview with The Epoch Times, Cancer surgeon Dr. Kathleen Ruddy revealed that she has seen several late-stage cancer patients make dramatic recoveries after taking ivermectin.

skymeds store | Online Ivermectin Pharmacy

102,675 views • 1 year ago

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.
1:44

84.4% of cancer patients taking ivermectin + mebendazole declared NO EVIDENCE OF DISEASE, TUMOR SHRINKAGE, or CANCER STABILIZATION after 6 months. HUNDREDS of preclinical studies explain why: anti-parasitics exert over 12 anti-cancer mechanisms across more than 12 cancer types.

Nicolas Hulscher, MPH

1,048,362 views • 2 months ago

🚨 Stage 4 Cancer – New Hope? A cancer patient shares how they’re using Ivermectin (anti-parasitic) + Fenbendazole (dewormer) as part of an alternative protocol to fight aggressive disease. 🧪 Both drugs have shown anti-cancer activity in lab studies: •Disrupt microtubules •Inhibit cancer metabolism •Support immune function 🔗 Buy Ivermectin and Fenbendazole from: or PharmacyinUSA.com 🌍 Worldwide Shipping | #CancerResearch #Ivermectin #Fenbendazole #HealthFreedom
14:51

🚨 Stage 4 Cancer – New Hope? A cancer patient shares how they’re using Ivermectin (anti-parasitic) + Fenbendazole (dewormer) as part of an alternative protocol to fight aggressive disease. 🧪 Both drugs have shown anti-cancer activity in lab studies: •Disrupt microtubules •Inhibit cancer metabolism •Support immune function 🔗 Buy Ivermectin and Fenbendazole from: or PharmacyinUSA.com 🌍 Worldwide Shipping | #CancerResearch #Ivermectin #Fenbendazole #HealthFreedom

Camus

18,451 views • 11 months ago

🚨 DR. WILLIAM MAKIS MD CALLS THIS THE MOST IMPORTANT IVERMECTIN CANCER GRAPH HE'S EVER CREATED After reviewing hundreds of studies, case reports, and patient outcomes, Dr. William Makis MD says one question keeps coming up: ❓"What dose of Ivermectin are people actually using in cancer protocols?" His answer is surprisingly simple. 💊 For most cancers, his suggested starting point is: 1 mg/kg of Ivermectin per day 📊 THE FOUR IVERMECTIN DOSING LEVELS DR. MAKIS DISCUSSES MOST OFTEN 🔹 0.2 mg/kg daily Lower-dose protocols discussed in some case reports and published reports. 🔹 1.0 mg/kg daily Dr. Makis' typical starting point for most cancers. 🔹 2.0 mg/kg daily Discussed for highly aggressive cancers, including some brain cancers. 🔹 2.5 mg/kg daily The highest dosing level discussed in certain case reports. According to Dr. Makis, some of the most widely discussed case reports involve higher dosing strategies. And that's where the conversation gets interesting. Because this isn't being discussed for just one type of cancer. Researchers have investigated Ivermectin in: ✅ Breast Cancer ✅ Colon Cancer ✅ Lung Cancer ✅ Pancreatic Cancer ✅ Kidney Cancer ✅ Gastric Cancer ✅ Prostate Cancer ✅ Brain Cancer ✅ Leukemia And many others. Dr. Makis frequently points to reports involving significant changes in tumor markers, imaging results, and patient outcomes that continue driving interest in repurposed medicines. He also highlights something many people overlook: ✅ Off patent ✅ Generic ✅ Low cost ✅ Studied for decades Yet despite the growing number of publications and case reports, mainstream oncology rarely discusses it. That's why the debate keeps growing. Not because everyone agrees. Because patients keep sharing stories. Doctors keep debating. Researchers keep publishing. And people keep asking questions. Because if the answer were obvious... The conversation would've ended years ago. Instead, it's getting bigger. 📌 Save this chart. You'll want it later. 🔄 Repost so others can review the information for themselves. 💬 Have you been following Dr. William Makis MD's work on Ivermectin and cancer? 💊 Researching Ivermectin? Explore RXMEDS.store. #Ivermectin #CancerResearch #MakisMD #RepurposedDrugs
5:47

🚨 DR. WILLIAM MAKIS MD CALLS THIS THE MOST IMPORTANT IVERMECTIN CANCER GRAPH HE'S EVER CREATED After reviewing hundreds of studies, case reports, and patient outcomes, Dr. William Makis MD says one question keeps coming up: ❓"What dose of Ivermectin are people actually using in cancer protocols?" His answer is surprisingly simple. 💊 For most cancers, his suggested starting point is: 1 mg/kg of Ivermectin per day 📊 THE FOUR IVERMECTIN DOSING LEVELS DR. MAKIS DISCUSSES MOST OFTEN 🔹 0.2 mg/kg daily Lower-dose protocols discussed in some case reports and published reports. 🔹 1.0 mg/kg daily Dr. Makis' typical starting point for most cancers. 🔹 2.0 mg/kg daily Discussed for highly aggressive cancers, including some brain cancers. 🔹 2.5 mg/kg daily The highest dosing level discussed in certain case reports. According to Dr. Makis, some of the most widely discussed case reports involve higher dosing strategies. And that's where the conversation gets interesting. Because this isn't being discussed for just one type of cancer. Researchers have investigated Ivermectin in: ✅ Breast Cancer ✅ Colon Cancer ✅ Lung Cancer ✅ Pancreatic Cancer ✅ Kidney Cancer ✅ Gastric Cancer ✅ Prostate Cancer ✅ Brain Cancer ✅ Leukemia And many others. Dr. Makis frequently points to reports involving significant changes in tumor markers, imaging results, and patient outcomes that continue driving interest in repurposed medicines. He also highlights something many people overlook: ✅ Off patent ✅ Generic ✅ Low cost ✅ Studied for decades Yet despite the growing number of publications and case reports, mainstream oncology rarely discusses it. That's why the debate keeps growing. Not because everyone agrees. Because patients keep sharing stories. Doctors keep debating. Researchers keep publishing. And people keep asking questions. Because if the answer were obvious... The conversation would've ended years ago. Instead, it's getting bigger. 📌 Save this chart. You'll want it later. 🔄 Repost so others can review the information for themselves. 💬 Have you been following Dr. William Makis MD's work on Ivermectin and cancer? 💊 Researching Ivermectin? Explore RXMEDS.store. #Ivermectin #CancerResearch #MakisMD #RepurposedDrugs

RXMEDS.store

47,857 views • 14 days ago

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD
4:13

The Remarkable Cancer-Fighting Benefits of Ivermectin • “Ivermectin can actually kill cancer stem cells,” which are often resistant to chemotherapy. • “It can also reverse resistance that cancer cells develop to chemotherapy,” making treatments more effective. • “It makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer.” • Patients are seeing “tumors shrinking down to almost nothing, liver metastases disappearing, [and] brain metastases disappearing.” “There are over 100 papers on the success of ivermectin and cancer,” but much of this research has been ignored because the drug is off-patent, meaning “no one’s going to make money on it.” Dr. Makis has treated over 1,000 patients using combinations of ivermectin, fenbendazole, and other therapies. Many of his patients, told by their doctors that there was “nothing they can do for them,” are now “cancer-free” or have their “cancer under control.” The success stories are undeniable, and the hope is spreading. MakisMD

skymeds store | Online Ivermectin Pharmacy

5,142,525 views • 1 year ago

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Follow me.
1:37

Ivermectin and Mebendazole Hit Cancer Cells Six Different Ways. Chemo Usually Hits One. That's why combination chemotherapy exists — because cancer has to be attacked through multiple mechanisms simultaneously. Ivermectin and mebendazole together do exactly that: blocking cell division, cutting off glucose metabolism, targeting cancer stem cells, and more. Six distinct anti-cancer mechanisms in one affordable, already-approved combination. Follow me.

Joe Tippens

18,133 views • 2 months ago

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.
1:28

Studies have shown that certain electromagnetic frequencies, particularly in the low-range (100 to 300 Hz), may have the potential to disrupt cancer cell function and induce cell death, or apoptosis. Research suggests that these frequencies can interfere with cellular mechanisms by affecting ion channels and membrane potentials, disrupting cancer cells' ability to replicate and survive. One notable frequency, 100 Hz, has been explored in preclinical studies, where it was found to selectively impair cancer cells without significantly damaging healthy tissues. However, more clinical studies are required to validate the therapeutic potential of frequency-based treatments for cancer.

Barbara Oneill

114,837 views • 1 year ago

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure
3:49

Oncologist Dr. William Makis: "Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer...[and is] running, quietly, several clinical trials with mebendazole in cancer...So this is not fringe... There's... real science behind it, patents behind it." "For the past year and a half, I've been working with antiparasitics that are being repurposed for cancer. This is ivermectin, mebendazole and fenbendazole. And the reason is because there's a big body of research. There are over 400 published papers on ivermectin in cancer. There are over 240 published papers on mebendazole in cancer. "In fact, Johns Hopkins quietly secured a patent in 2021 on mebendazole for treatment in cancer, specifically the most aggressive cancer, which is glioblastoma, brain cancer, extremely aggressive cancer. Johns Hopkins has the patent. They are also running quietly several clinical trials with mebendazole in cancer. There's colon cancer, gastric cancer and brain cancer, including children, children with brain cancers as well. So this is not fringe, this is not, something that is far out. There's actually real science behind it, patents behind it. Dr. Sulack Pete "And when you search a lot of the AIs, for example Perplexity AI and you ask what are the most promising repurposed drugs for terminally ill cancer patients today, it will give you in its search, in the top three, you will get ivermectin as number one, mebendazole and fenbendazole, there's other antiparasitics like hydroxychloroquine will be in the top 10, you will have curcumin in the top 10, you will have EGCG, which is from green tea extract in the top 10, resveratrol in the top 10, metformin, which is a diabetes drug but also has anti-cancer activity in the top 10 as well. "And what I have found working with these antiparasitics, is that there is a benefit to patients in at least 75% of the cases." #Fenbendazole #Ivermectin #Cancercure

Joe Tippens

166,528 views • 7 months ago

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)
22:06

Ivermectin & Fenbendazole Cancer Secrets Revealed w/ Dr. William Makis Remarkable success stories are pouring in from people using Ivermectin and Fenbendazole to combat cancer. Mel Gibson dropped a bombshell on Joe Rogan’s podcast, revealing that three of his friends had “stage four cancer,” and now “all three of them don’t have cancer right now at all.” “And they had some serious stuff going on,” Gibson emphasized. Dr. William Makis, who treated one of Gibson’s friends, has been rigorously researching the anti-cancer potential of Ivermectin and Fenbendazole over the past two years. During that time, he discovered, “There are over 100 papers on the success of Ivermectin and cancer.” “Ivermectin can actually kill cancer stem cells,” Dr. Makis explained, noting that it targets the cells “that chemo can’t kill.” He added, “It can also reverse resistance that cancer cells develop to certain types of chemotherapy.” The benefits extend further. “It [Ivermectin] makes cancer cells susceptible to radiation treatment as well. And so it’s a radiosensitizer,” he shared. Yet, research into these applications has been neglected. “Big Pharma has completely abandoned it. Ivermectin is off-patent. No one’s going to make money on it,” Dr. Makis pointed out. Taking action where others haven’t, Dr. Makis applied his findings to his practice. “I have over 1,000 cancer patients who are on either a combination of Ivermectin and Fenbendazole or Ivermectin and Mebendazole,” he shared. Some of his patients were “given a terminal diagnosis” but are now “cancer-free” or have their “cancer under control.” “Patients, for example, who are taking combinations of chemo and Ivermectin or radiation and Ivermectin are seeing dramatic results that oncologists have never seen, that radiation oncologists have never seen,” Dr. Makis shared. “Tumors shrinking down to almost nothing, liver metastases disappearing, brain metastases disappearing.” “There are hundreds, if not thousands, of testimonials” documenting the success stories of Ivermectin and Fenbendazole, Dr. Makis added, offering hope to patients seeking alternatives. He strongly believes that “the future of cancer care is in repurposed drugs.” For more information on the use of Ivermectin and Fenbendazole for cancer, follow Dr. William Makis (MakisMD) on 𝕏. --> MakisMD (See 9 More Revealing Stories Below)

The Vigilant Fox 🦊

1,291,982 views • 1 year ago

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 views • 2 years ago

REPORT: Ivermectin Shows Striking Anti-Cancer Potential in Patients Diagnosed With Parasites It turns out that when cancer patients were treated with ivermectin to eliminate parasitic infections, some saw stunning, unexpected improvements in their cancer outcomes. Dr Henry Ealy says he doesn’t believe this is just a coincidence. “We learned that the cancer was driven by infections, and this is killing those infections,” he said. This segment is a true eye-opener. You may never look at cancer the same way again.
5:59

REPORT: Ivermectin Shows Striking Anti-Cancer Potential in Patients Diagnosed With Parasites It turns out that when cancer patients were treated with ivermectin to eliminate parasitic infections, some saw stunning, unexpected improvements in their cancer outcomes. Dr Henry Ealy says he doesn’t believe this is just a coincidence. “We learned that the cancer was driven by infections, and this is killing those infections,” he said. This segment is a true eye-opener. You may never look at cancer the same way again.

The Vigilant Fox 🦊

94,009 views • 1 year ago

🚨 "Ivermectin cure 28 types of Cancer" While headlines mocked ivermectin, researchers quietly tested it across 28 cancer types. The findings showed: • Slowed tumor cell growth • Targeted resistant cancer cells • Boosted chemo effectiveness Yet the public narrative stayed the same. “Don’t take it.” When a low cost, off patent drug shows potential, it raises uncomfortable questions about profit, power, and who controls the story. If you’re exploring repurposed options like Ivermectin, Fenbendazole, or Mebendazole, visit GENIX MEDS for worldwide delivery at an affordable rate without any Rx. #Ivermectin #CancerResearch #RepurposedDrugs #cancercure
12:19

🚨 "Ivermectin cure 28 types of Cancer" While headlines mocked ivermectin, researchers quietly tested it across 28 cancer types. The findings showed: • Slowed tumor cell growth • Targeted resistant cancer cells • Boosted chemo effectiveness Yet the public narrative stayed the same. “Don’t take it.” When a low cost, off patent drug shows potential, it raises uncomfortable questions about profit, power, and who controls the story. If you’re exploring repurposed options like Ivermectin, Fenbendazole, or Mebendazole, visit GENIX MEDS for worldwide delivery at an affordable rate without any Rx. #Ivermectin #CancerResearch #RepurposedDrugs #cancercure

GENIX MEDS

24,089 views • 4 months ago

💊 The Use of Ivermectin in Cancer 🤔 What if a common drug had hidden potential? Research suggests Ivermectin may play a role beyond its known use — challenging the conventional cancer narrative ✨ Truth in medicine is always worth exploring ✨ 👉 What are your thoughts on repurposed treatments? Share below💬
1:07

💊 The Use of Ivermectin in Cancer 🤔 What if a common drug had hidden potential? Research suggests Ivermectin may play a role beyond its known use — challenging the conventional cancer narrative ✨ Truth in medicine is always worth exploring ✨ 👉 What are your thoughts on repurposed treatments? Share below💬

skymeds store | Online Ivermectin Pharmacy

20,810 views • 1 year ago

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️
0:37

Over 100 studies show Ivermectin does in fact contain anti-cancer mechanisms across 12 types of cancer. It was known decades ago that anti-parasitic medications reduced cancer but was hidden from the pubic -new studies are bringing it back into the light. See comment below ⬇️

Catturd ™

251,666 views • 1 month ago

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.
1:17

Parasite drugs that kill cancer cells? The industry jacks up the price. Dr. Thomas Seyfried says cheap medications like Mebendazole and Fenbendazole target the same metabolic pathways in cancer cells that parasites use to survive. But once they show promise, the price skyrockets. He compared it to Martin Shkreli hiking EpiPen costs. Repurposed drugs like Mebendazole have shown anti-cancer effects in preclinical studies by disrupting microtubule function and glutamine metabolism in tumor cells, but large-scale clinical trials in humans are still limited.

Camus

36,269 views • 7 days ago

🚨First Lady Casey DeSantis says Florida invests in IVERMECTIN as a possible cure for cancer. “In Florida we have invested over a billion dollars in cancer care and research. We’ve also looked into innovative research like Ivermectin and its potential to try to combat cancer.”
0:33

🚨First Lady Casey DeSantis says Florida invests in IVERMECTIN as a possible cure for cancer. “In Florida we have invested over a billion dollars in cancer care and research. We’ve also looked into innovative research like Ivermectin and its potential to try to combat cancer.”

Chris Nelson 🏝️🇺🇸

60,034 views • 5 months ago